For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Arm I (Low Risk for Graft Failure) | Patients receive a conditioning regimen comprising fludarabine phosphate IV over 1 hour every day (QD) on days -6 to -2 and treosulfan IV over 120 minutes on days - 6 to -4. Patients undergo (total body irradiation (TBI) on day -1. Patients then undergo donor cord blood transplantation (CBT) on day 0. Patients receive graft-versus-host disease (GVHD) prophylaxis comprising cyclosporine IV over 1 hour or by mouth (PO) 2-3 times daily on days -3 to 100, followed by a taper in the absence of GVHD. Patients also receive mycophenolate mofetil IV 3 times daily on days 0 to 40, followed by a taper in the absence of GVHD. Cyclosporine: Given IV or PO Fludarabine Phosphate: Given IV Laboratory Biomarker Analysis: Correlative studies Mycophenolate Mofetil: Given IV Total-Body Irradiation: TBI administered day -1: 200 centigray (cGy) (or escalated to 300 cGy, 400 cGy, or 450 cGy per protocol statistical section) Treosulfan: Given IV Umbilical Cord Blood Transplantation (UCBT): Undergo single or double unit UCBT | 16 | None | 27 | 66 | 63 | 66 | View |
| Arm II (High Risk for Graft Failure) | Patients receive a conditioning regimen, TBI, donor UCBT, GVHD prophylaxis, and mycophenolate mofetil as in Arm I. Cyclosporine: Given IV or PO Fludarabine Phosphate: Given IV Laboratory Biomarker Analysis: Correlative studies Mycophenolate Mofetil: Given IV Total-Body Irradiation: TBI administered day -1: 200 cGy (or escalated to 300 cGy, 400 cGy, or 450 cGy per protocol statistical section) Treosulfan: Given IV Umbilical Cord Blood Transplantation: Undergo single or double unit UCBT | 20 | None | 23 | 64 | 59 | 64 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Allergic Reaction | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Acute cardiomyopathy | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Left Ventricular Systolic dysfunction | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Cardiac troponin I increased | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Pericarditis | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Multi-organ failure | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Infusional Toxicity/Stunned Heart | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Heart Failure | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Sinusoidal obstruction syndrome | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Gastrointestinal hemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Anal hemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Bronchopulmonary hemorrhage | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Respiratory failure | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Hypoxia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Renal failure | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Seizure | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Psychosis | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Myelitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Encephalopathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Cognitive disturbance | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Other - autonomic dysreflexia exacerbation | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Proteinuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Upper respiratory infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Anorectal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Encephalitis infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Atrial Flutter | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Sinus tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Heart Failure | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Portal vein thrombosis | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Disemminated vascular coagulation | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Sinusoidal obstruction syndrome | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Rash maculopapular | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Colitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Gastric Ulcer | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Mucositis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Pancreatitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Pericardial effusion | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Gatritis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Seizure | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Otitis Externa | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Bacteremia | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Duodenal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Thromboembolic event | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Allergic Reaction | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Hemolysis | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Atrial Fibrillation | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Bronchopulmonary hemorrhage | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Gastric hemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Blood bilirubin increased | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Febrile Neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Lung infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Skin infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Encephalitis infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Enterocolitis infectious | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Eye infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Upper respiratory infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Syncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Apnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Hypoxia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Creatinine increased | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Renal failure | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Left Ventricular Systolic dysfunction | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Pericarditis | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Epistaxis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Oral cavity | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Other: genitourinary | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Sinusitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Anorectal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Other: pulmonary insufficiency | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Other: Thrombosis | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Other: Coagulopathy | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Other: Thrombotic microangiopathy | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Other: Genitalia infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Other: Melena | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |